Peptron Inc. | Mutual Funds
Mutual Funds that own Peptron Inc.
Vanguard Total International Stock Index Fund
179,002
1.17%
0
0%
07/31/2018
Vanguard Developed Markets Index Fund
70,948
0.46%
0
0%
07/31/2018
Government Pension Fund - Global (The)
37,504
0.25%
21,502
0%
12/31/2017
Vanguard FTSE All World (ex-US) Small Cap
30,902
0.2%
0
0.01%
07/31/2018
Mirae Asset TIGER Health Care ETF
26,334
0.17%
6,424
0.44%
04/30/2018
Schwab International Small Cap Equity ETF
21,967
0.14%
0
0.02%
09/06/2018
SPDR S&P International Small Cap ETF
14,618
0.1%
0
0.04%
09/06/2018
Vanguard Pacific Stock Index Fund
14,470
0.09%
0
0.01%
07/31/2018
iShares III Plc - MSCI Emerging Markets Small Cap
7,336
0.05%
0
0.04%
09/05/2018
iShares MSCI Emerging Markets Small Cap ETF
6,726
0.04%
0
0.06%
09/05/2018
| Address |
37-24 Yuseong-daero 1628beon-gil
Daejeon DE 34054
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.peptron.co.kr |
| Updated |
09/14/2018 |
| Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative neuronal disease, and obesity, peptide materials, and cosmetics. The company was founded on November 21, 1997 and is headquartered in Daejeon, South Korea. |
